IE922400L - Composition comprising an oxygen radical scavenger and a¹surface-active copolymer - Google Patents

Composition comprising an oxygen radical scavenger and a¹surface-active copolymer

Info

Publication number
IE922400L
IE922400L IE922400A IE922400A IE922400L IE 922400 L IE922400 L IE 922400L IE 922400 A IE922400 A IE 922400A IE 922400 A IE922400 A IE 922400A IE 922400 L IE922400 L IE 922400L
Authority
IE
Ireland
Prior art keywords
composition
active copolymer
c2h4o
approximately
fibrinolytic
Prior art date
Application number
IE922400A
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/045,459 external-priority patent/US4801452A/en
Application filed by Univ Emory filed Critical Univ Emory
Publication of IE922400L publication Critical patent/IE922400L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"IMPROVED FIBRINOLYTIC COMPOSITION" of the Invention In accordance with the present invention, a composition is provided that is effective in dissolving blood clots and reestablishing and maintaining blood flow through thrombosed coronary or other blood vessels. The fibrinolytic composition of the present invention comprises an enzyme, such as streptokinase, urokinase, tissue plasminogen activator or other fibrinolytic enzyme, and a surface-active copolymer. The surface-active copolymer can be an ethylene oxide-propylene oxide condensation product with the following general formula: HO(C2H4O)b(C3H6O)a(C2H4O)bH wherein a is an integer such that the hydrophobe represented by (C3H6O) has a molecular weight of approximately 950 to 4000, preferably approximately 1750 to 3500, and b is an integer such that the hydrophile portion represented by (C2H4O) constitutes approximately 50% to 90% by weight of the compound. [CA1297792C]
IE922400A 1986-05-15 1987-05-14 Composition comprising an oxygen radical scavenger and a¹surface-active copolymer IE922400L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86358286A 1986-05-15 1986-05-15
US07/045,459 US4801452A (en) 1986-05-15 1987-05-07 Fibrinolytic composition

Publications (1)

Publication Number Publication Date
IE922400L true IE922400L (en) 1987-11-15

Family

ID=26722792

Family Applications (4)

Application Number Title Priority Date Filing Date
IE922400A IE922400L (en) 1986-05-15 1987-05-14 Composition comprising an oxygen radical scavenger and a¹surface-active copolymer
IE922399A IE922399L (en) 1986-05-15 1987-05-14 An ex vivo tissue perfusion composition and the use thereof
IE126187A IE62088B1 (en) 1986-05-15 1987-05-14 Fibrinolytic composition
IE922401A IE922401L (en) 1986-05-15 1987-05-14 An injectable pharmaceutical composition for the¹protectionof tissue damaged by ischemia

Family Applications After (3)

Application Number Title Priority Date Filing Date
IE922399A IE922399L (en) 1986-05-15 1987-05-14 An ex vivo tissue perfusion composition and the use thereof
IE126187A IE62088B1 (en) 1986-05-15 1987-05-14 Fibrinolytic composition
IE922401A IE922401L (en) 1986-05-15 1987-05-14 An injectable pharmaceutical composition for the¹protectionof tissue damaged by ischemia

Country Status (6)

Country Link
CA (1) CA1297792C (en)
GR (1) GR870758B (en)
IE (4) IE922400L (en)
NZ (1) NZ220288A (en)
PH (1) PH25909A (en)
PT (1) PT84880B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3170396A1 (en) 2007-02-19 2017-05-24 Plurogen Therapeutics, Inc. Compositions for treating biofilms and methods for using same
CA2974361A1 (en) 2015-01-20 2016-07-28 Plurogen Therapeutics, Llc Compositions and methods of treating microbes

Also Published As

Publication number Publication date
IE922399L (en) 1987-11-15
PT84880A (en) 1987-06-01
PT84880B (en) 1990-02-08
GR870758B (en) 1988-05-24
PH25909A (en) 1991-12-19
CA1297792C (en) 1992-03-24
NZ220288A (en) 1989-08-29
IE62088B1 (en) 1994-12-14
IE871261L (en) 1987-11-15
IE922401L (en) 1987-11-15

Similar Documents

Publication Publication Date Title
ES2009264A6 (en) Fibrinolytic composition
CA2006953A1 (en) Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids.
US4326977A (en) Liquid antiseptic cleaners with improved foaming properties
CA2106474A1 (en) Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
EP0266419A4 (en) Fibrinolytic composition.
IE40434L (en) Pharmaceutical compositions.
EP0299787A3 (en) Cloth-softening liquid composition
CA2178760A1 (en) HIV Protease Inhibitors
KR890000103A (en) Method for preparing high concentration solution of protein with tissue plasminogen activator (t-PA) activity, solution containing protein with t-PA activity, and use of solution in human and veterinary medicine
IE922400L (en) Composition comprising an oxygen radical scavenger and a¹surface-active copolymer
CA2062779A1 (en) Sterilizing gas composition comprising monochlorotetrafluorethane and ethylene oxide
ES2169052T3 (en) PREPARED LIQUID ENZYMATICS.
US5925350A (en) Use of preparation comprising a plasminogen activator to improve wound healing
ES8802579A1 (en) Rinse aid composition
JPS55135590A (en) Modified asparaginase and uricase and their preparation
JPS5692217A (en) Easily absorbable enzyme preparation
JPS57207640A (en) Treating agent composition
MY104998A (en) Detergent composition
EP0154432B1 (en) Modified urokinase composition
JPS6450844A (en) Novel fluorine-containing compound and use thereof
HUT47431A (en) Process for producing fibrinolytic compositions
EP0314042A3 (en) Novel copolymers and superoxide dismutase modified with said copolymers
NO880141L (en) IMPROVED FIBRINOLYTIC MIXING.
CA2075901A1 (en) Tissue plasminogen activator having fibrin specific properties
Suzuki et al. A study on the properties of commercial thrombin preparations

Legal Events

Date Code Title Description
FA9A Application withdrawn section 33(1)